Comparison of Dental Benzodiazepine Prescriptions From the U.S., England, and Australia From 2013 to 2018
- PMID: 33775512
- PMCID: PMC8542255
- DOI: 10.1016/j.amepre.2021.01.025
Comparison of Dental Benzodiazepine Prescriptions From the U.S., England, and Australia From 2013 to 2018
Abstract
Introduction: Benzodiazepines contribute to substance use disorder and are often part of polydrug abuse, most frequently with opioids. Although dental opioid prescribing differs significantly between countries, little is known about the patterns of dental benzodiazepine prescribing. The aim of this study is to compare dental prescribing of benzodiazepines among the U.S., England, and Australia in 2013-2018.
Methods: Population-level data were accessed from national data sets for each country for dental benzodiazepine prescriptions. Outcome measures of dental benzodiazepine prescribing included: (1) prescribing rates by population for each year and (2) the quantity and relative proportion of benzodiazepines by type for each country. The analysis was conducted in 2020.
Results: Between 2013 and 2018, U.S. dentists prescribed 23 times more than English dentists and 7 times more than Australian dentists by population. During the study period, the rate of dental benzodiazepine prescribing decreased in England and the U.S. but increased in Australia. Despite these trends, U.S. dental prescribing rates remained 28 times more than English dentists and 6 times more than Australian dentists in 2018 (U.S., 3.10 prescriptions/1,000 population; England, 0.11 prescriptions/1,000 population; Australia, 0.50 prescriptions/1,000 population). U.S. dentists prescribed a wider variety of benzodiazepines than English and Australian dentists. Diazepam was most commonly prescribed in all countries. In the U.S., triazolam, lorazepam, and alprazolam were next most commonly prescribed. Temazepam was next most frequent in England and Australia.
Conclusions: Significant variation in benzodiazepine prescribing rates and types were seen among the countries. To improve patient safety, further investigation into the appropriate use and choices of benzodiazepines in dentistry is needed.
Copyright © 2021 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Comparison of Opioid Prescribing by Dentists in the United States and England.JAMA Netw Open. 2019 May 3;2(5):e194303. doi: 10.1001/jamanetworkopen.2019.4303. JAMA Netw Open. 2019. PMID: 31125102 Free PMC article.
-
Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1. MMWR Surveill Summ. 2015. PMID: 26469747
-
Trends in Opioid Prescribing by General Dentists and Dental Specialists in the U.S., 2012-2019.Am J Prev Med. 2022 Jul;63(1):3-12. doi: 10.1016/j.amepre.2022.01.009. Epub 2022 Feb 26. Am J Prev Med. 2022. PMID: 35232618 Free PMC article.
-
A scoping review exploring the opioid prescribing practices of US dental professionals.J Am Dent Assoc. 2018 Dec;149(12):1011-1023. doi: 10.1016/j.adaj.2018.07.017. Epub 2018 Sep 8. J Am Dent Assoc. 2018. PMID: 30205900 Review.
-
Chronic use of benzodiazepines: The problem that persists.Int J Psychiatry Med. 2023 Sep;58(5):426-432. doi: 10.1177/00912174231166252. Epub 2023 Mar 27. Int J Psychiatry Med. 2023. PMID: 36972700 Review.
Cited by
-
The use of oral benzodiazepines for the management of dental anxiety: a web-based survey of UK dentists.Br Dent J. 2023 May 24:1-5. doi: 10.1038/s41415-023-5850-5. Online ahead of print. Br Dent J. 2023. PMID: 37225841 Free PMC article.
-
Distribution of Opioid Prescribing and High-Risk Prescribing Among U.S. Dentists in 2019.Am J Prev Med. 2022 Mar;62(3):317-325. doi: 10.1016/j.amepre.2021.09.017. Am J Prev Med. 2022. PMID: 35190099 Free PMC article.
-
GABAkines - Advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors.Pharmacol Ther. 2022 Jun;234:108035. doi: 10.1016/j.pharmthera.2021.108035. Epub 2021 Nov 16. Pharmacol Ther. 2022. PMID: 34793859 Free PMC article. Review.
References
-
- Calcaterra SL, Severtson SG, Bau GE, Margolin ZR, Bucher-Bartelson B, Green JL, et al. Trends in intentional abuse or misuse of benzodiazepines and opioid analgesics and the associated mortality reported to poison centers across the United States from 2000 to 2014. Clin Toxicol (Phila). 2018;56(11):1107–14. - PubMed
-
- Durkin M Pharmaceutical drug misuse in Australia. Australian Prescriber. 2014;37:79–81.
-
- Longo LP, Johnson B. Addiction: Part I. Benzodiazepines--side effects, abuse risk and alternatives. Am Fam Physician. 2000;61(7):2121–8. - PubMed
-
- Gold MS MN, Stennie K, Populla-Varch C. Epidemiology of benzodiazepine use and dependence. Psychiatric Annals. 1995(25):146–8.
-
- Friedrich JM, Sun C, Geng X, Calello DP, Gillam M, Medeiros KL, et al. Child and adolescent benzodiazepine exposure and overdose in the United States: 16 years of poison center data. Clin Toxicol (Phila). 2020;58(7):725–31. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
